ID   KTR4
AC   CVCL_E9WG
RX   PubMed=12842705;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D200 ! KT-1 [Human leukemia]
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=12842705; DOI=10.1016/s0301-472x(03)00089-4;
RA   Shimizu, Takatsune
RA   Miyakawa, Yoshitaka
RA   Oda, Atsushi
RA   Kizaki, Masahiro
RA   Ikeda, Yasuo
RT   "STI571-resistant KT-1 cells are sensitive to interferon-alpha
RT   accompanied by the loss of T-cell protein tyrosine phosphatase and
RT   prolonged phosphorylation of Stat1.";
RL   Exp. Hematol. 31:601-608(2003).
//